Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2342-2350
Published online before print November 13, 2006, doi: 10.1161/CIRCULATIONAHA.105.598524
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/22/2342    most recent
CIRCULATIONAHA.105.598524v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Silva, R.
Right arrow Articles by Lederman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Silva, R.
Right arrow Articles by Lederman, R. J.
Related Collections
Right arrow Animal models of human disease
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow CT and MRI
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Circulation. 2006;114:2342-2350.)
© 2006 American Heart Association, Inc.


Imaging

X-Ray Fused With Magnetic Resonance Imaging (XFM) to Target Endomyocardial Injections

Validation in a Swine Model of Myocardial Infarction

Ranil de Silva, MRCP, PhD*; Luis F. Gutiérrez, PhD*; Amish N. Raval, MD; Elliot R. McVeigh, PhD; Cengizhan Ozturk, MD, PhD; Robert J. Lederman, MD

From the Cardiovascular Branch (R.d.S., A.N.R., C.O., R.J.L.) and Laboratory of Cardiac Energetics (L.F.G., E.R.M.), Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Md (L.F.G., E.R.M.).

Correspondence to Robert J. Lederman, MD, Cardiovascular Branch, Bldg 10, Room 2C713, Bethesda, MD 20892-1538. E-mail ledermar{at}nhlbi.nih.gov

Received November 3, 2005; revision received September 19, 2006; accepted September 22, 2006.

Background— Magnetic resonance imaging (MRI) permits 3-dimensional (3D) cardiac imaging with high soft tissue contrast. X-ray fluoroscopy provides high-resolution, 2-dimensional (2D) projection imaging. We have developed real-time x-ray fused with MRI (XFM) to guide invasive procedures that combines the best features of both imaging modalities. We tested the accuracy of XFM using external fiducial markers to guide endomyocardial cell injections in infarcted swine hearts.

Methods and Results— Endomyocardial injections of iron-labeled mesenchymal stromal cells admixed with tissue dye were performed in previously infarcted hearts of 12 Yucatan miniswine (weight, 33 to 67 kg). Features from cardiac MRI were displayed combined with x-ray in real time to guide injections. During 130 injections, operators were provided with 3D surfaces of endocardium, epicardium, myocardial wall thickness (range, 2.6 to 17.7 mm), and infarct registered with live x-ray images to facilitate device navigation and choice of injection location. XFM-guided injections were compared with postinjection MRI and with necropsy specimens obtained 24 hours later. Visual inspection of the pattern of dye staining on 2,3,5-triphenyltetrazolium chloride–stained heart slices agreed ({kappa}=0.69) with XFM-derived injection locations mapped onto delayed hyperenhancement MRI and the susceptibility artifacts seen on the postinjection T2*-weighted gradient echo MRI. The distance between the predicted and actual injection locations in vivo was 3.2±2.6 mm (n=64), and 75% of injections were within 4.1 mm of the predicted location.

Conclusions— Three-dimensional to two-dimensional registration of x-ray and MR images with the use of external fiducial markers accurately targets endomyocardial injection in a swine model of myocardial infarction.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. de Silva, A. N. Raval, M. Hadi, K. M. Gildea, A. C. Bonifacino, Z.-X. Yu, Y. Y. Yau, S. F. Leitman, S. L. Bacharach, R. E. Donahue, et al.
Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction
Eur. Heart J., July 2, 2008; 29(14): 1772 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. N. Ebert, D. G. Taylor, H.-L. Nguyen, D. P. Kodack, R. J. Beyers, Y. Xu, Z. Yang, and B. A. French
Noninvasive Tracking of Cardiac Embryonic Stem Cells In Vivo Using Magnetic Resonance Imaging Techniques
Stem Cells, November 1, 2007; 25(11): 2936 - 2944.
[Abstract] [Full Text] [PDF]